Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 148 articles:
HTML format
Text format



Single Articles


    August 2019
  1. KISHI T, Chipman J, Evereklian M, Nghiem K, et al
    Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    J Rheumatol. 2019 Aug 1. pii: jrheum.181275. doi: 10.3899/jrheum.181275.
    PubMed     Text format     Abstract available


    July 2019
  2. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Text format     Abstract available


  3. DE LUCA G, Campochiaro C, Dagna L
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy.
    J Rheumatol. 2019 Jul 1. pii: jrheum.190078. doi: 10.3899/jrheum.190078.
    PubMed     Text format     Abstract available


  4. LI C, Zhao J, Zhao Y
    Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:755-756.
    PubMed     Text format    


    June 2019
  5. STOJAN G, Magder LS, Petri M
    Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181131. doi: 10.3899/jrheum.181131.
    PubMed     Text format     Abstract available


  6. WONG PC, Lee G, Sedie AD, Hanova P, et al
    Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181087. doi: 10.3899/jrheum.181087.
    PubMed     Text format     Abstract available


  7. LI YC, Chang DM, Lu CC
    Montreal Cognitive Assessment and Magnetic Resonance Imaging Identify Cognitive Impairment in Young Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:653.
    PubMed     Text format    


  8. STAMATIS P, Turesson C, Willim M, Nilsson JA, et al
    Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study.
    J Rheumatol. 2019 Jun 1. pii: jrheum.190236. doi: 10.3899/jrheum.190236.
    PubMed     Text format     Abstract available


    May 2019
  9. FELDMAN CH, Malspeis S, Leatherwood C, Kubzansky L, et al
    Association of Childhood Abuse with Incident Systemic Lupus Erythematosus in Adulthood in a Longitudinal Cohort of Women.
    J Rheumatol. 2019 May 15. pii: jrheum.190009. doi: 10.3899/jrheum.190009.
    PubMed     Text format     Abstract available


  10. FUJISAWA T, Hozumi H, Yasui H, Suzuki Y, et al
    Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2019 May 15. pii: jrheum.180825. doi: 10.3899/jrheum.180825.
    PubMed     Text format     Abstract available


  11. BRUSCHI M, Bonanni A, Petretto A, Vaglio A, et al
    Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.
    J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232.
    PubMed     Text format     Abstract available


  12. ORMSETH MJ, Solus JF, Sheng Q, Ye F, et al
    Development and Validation of a microRNA Panel to Differentiate between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.
    J Rheumatol. 2019 May 15. pii: jrheum.181029. doi: 10.3899/jrheum.181029.
    PubMed     Text format     Abstract available


  13. BROUWER E, VAN DER Geest KSM, Sandovici M
    Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    J Rheumatol. 2019;46:453-454.
    PubMed     Text format    


    April 2019
  14. LEGGE A, Kirkland S, Rockwood K, Andreou P, et al
    Construction of a frailty index as a novel health measure in systemic lupus erythematosus.
    J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338.
    PubMed     Text format     Abstract available


  15. RUA-FIGUEROA I, Lopez-Longo F, Del Campo V, Galindo-Izquierdo M, et al
    Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes.
    J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882.
    PubMed     Text format     Abstract available


  16. MILLS BS, Dao KH, Tecson KM, Fishman E, et al
    Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network (PLAN) Registry.
    J Rheumatol. 2019 Apr 1. pii: jrheum.181067. doi: 10.3899/jrheum.181067.
    PubMed     Text format     Abstract available


  17. BESSE MC, Collercandy N, Diot E
    Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
    J Rheumatol. 2019;46:439.
    PubMed     Text format    


    March 2019
  18. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Text format     Abstract available


  19. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Text format     Abstract available


  20. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Text format     Abstract available


  21. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Text format     Abstract available


  22. TAMAI H, Nishina N, Takeuchi T
    Pulmonary Vein Vasculitis Presenting as Multiple Pulmonary Nodules in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:323-324.
    PubMed     Text format    


  23. SHA SJ, Hou JH, Xie GT, Sun W, et al
    Improvement of outcomes in patients with lupus nephritis: management evolution in Chinese patients from 1994 to 2010.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180145. doi: 10.3899/jrheum.180145.
    PubMed     Text format     Abstract available


  24. UGARTE-GIL MF, Wojdyla D, Pons-Estel GJ, Quintana R, et al
    Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180433. doi: 10.3899/jrheum.180433.
    PubMed     Text format     Abstract available


  25. SOLOMON IH, Docken WP, Padera RF
    Giant cell arteritis is not associated with varicella zoster virus in temporal artery biopsies or ascending aortic resections.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180912. doi: 10.3899/jrheum.180912.
    PubMed     Text format     Abstract available


    February 2019
  26. TAO JJ, Hiraki LT, Levy DM, Silverman ED, et al
    Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 15. pii: jrheum.180337. doi: 10.3899/jrheum.180337.
    PubMed     Text format     Abstract available


  27. BARBACKI A, Petri M, Avina-Zubieta A, Alarcon GS, et al
    Fatigue Measurements in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831.
    PubMed     Text format     Abstract available


  28. UROWITZ MB, Su J, Gladman DD
    Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180986. doi: 10.3899/jrheum.180986.
    PubMed     Text format     Abstract available


  29. LIU LH, Fevrier HB, Goldfien R, Hemmerling A, et al
    Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180946. doi: 10.3899/jrheum.180946.
    PubMed     Text format     Abstract available


    January 2019
  30. MERAYO-CHALICO J, Barrera-Vargas A, Morales-Padilla S, Reyna-De la Garza R, et al
    Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180292. doi: 10.3899/jrheum.180292.
    PubMed     Text format     Abstract available


  31. WIRESTAM L, Enocsson H, Skogh T, Padyukov L, et al
    Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180713. doi: 10.3899/jrheum.180713.
    PubMed     Text format     Abstract available


  32. QUEVEDO-ABELEDO JC, Rua-Figueroa I, Sanchez-Perez H, Tejera-Segura B, et al
    Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180881. doi: 10.3899/jrheum.180881.
    PubMed     Text format     Abstract available


  33. KOSTER MJ, Yeruva K, Crowson CS, Muratore F, et al
    Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180429. doi: 10.3899/jrheum.180429.
    PubMed     Text format     Abstract available


  34. BREKKE LK, Fevang BT, Myklebust G
    Increased Incidence of Giant Cell Arteritis in Urban Areas?
    J Rheumatol. 2019 Jan 15. pii: jrheum.180714. doi: 10.3899/jrheum.180714.
    PubMed     Text format     Abstract available


  35. HOZUMI H, Fujisawa T, Nakashima R, Yasui H, et al
    Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180778. doi: 10.3899/jrheum.180778.
    PubMed     Text format     Abstract available


  36. ZHANG S, Zhang F, Li Y
    Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
    J Rheumatol. 2019;46:114-116.
    PubMed     Text format    


    December 2018
  37. JOHNSON SR, Khanna D, Daikh D, Cervera R, et al
    Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180478. doi: 10.3899/jrheum.180478.
    PubMed     Text format     Abstract available


  38. VAN ROON AM, Huisman CC, van Roon AM, Zhang D, et al
    Abnormal Nailfold Capillaroscopy Is Common in Patients with Connective Tissue Disease and Associated with Abnormal Pulmonary Function Tests.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180615. doi: 10.3899/jrheum.180615.
    PubMed     Text format     Abstract available


  39. HAGEN M, Englbrecht M, Haschka J, Reiser M, et al
    Cost-effective Tapering Algorithm in Rheumatoid Arthritis Patients: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180028. doi: 10.3899/jrheum.180028.
    PubMed     Text format     Abstract available


  40. SUN YS, Huang DF, Lin FC, Hsu CK, et al
    Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180104. doi: 10.3899/jrheum.180104.
    PubMed     Text format     Abstract available



  41. The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial.
    J Rheumatol. 2018;45:1713.
    PubMed     Text format    


  42. GREMESE E, DE Lorenzis E, Ferraccioli GF
    Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?
    J Rheumatol. 2018;45:1617-1619.
    PubMed     Text format    


    November 2018
  43. MAESHIMA K, Ishii K, Shibata H
    An Adult Fatal Case with a STAT1 Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.
    J Rheumatol. 2018 Nov 15. pii: jrheum.180210. doi: 10.3899/jrheum.180210.
    PubMed     Text format     Abstract available


  44. UGOLINI R, Muratore F, Salvarani C
    Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell Arteritis.
    J Rheumatol. 2018;45:1603-1604.
    PubMed     Text format    


    October 2018
  45. TSELIOS K, Deeb M, Gladman DD, Harvey P, et al
    Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
    J Rheumatol. 2018 Oct 15. pii: jrheum.180124. doi: 10.3899/jrheum.180124.
    PubMed     Text format     Abstract available


  46. YAMADA S, Nagafuchi Y, Fujio K
    Retro-odontoid Pseudotumor Associated with Sjogren Syndrome and Systemic Lupus Erythematosus Serology.
    J Rheumatol. 2018;45:1424-1425.
    PubMed     Text format    


  47. YAP DYH, Tang C, Chan GCW, Kwan LPY, et al
    Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
    J Rheumatol. 2018 Oct 1. pii: jrheum.180507. doi: 10.3899/jrheum.180507.
    PubMed     Text format     Abstract available


    September 2018
  48. PESCHKEN CA, Wang Y, Abrahamowicz M, Pope J, et al
    Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 15. pii: jrheum.171454. doi: 10.3899/jrheum.171454.
    PubMed     Text format     Abstract available


  49. VAN DELFT MAM, van Beest S, Kloppenburg M, Trouw LA, et al
    Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180256. doi: 10.3899/jrheum.180256.
    PubMed     Text format     Abstract available


  50. FAGUER S, Belliere J, Ribes D
    Complement C5-blocking Agent in Refractory Dermatomyositis.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180060. doi: 10.3899/jrheum.180060.
    PubMed     Text format     Abstract available


  51. JORGE AM, Lu N, Keller SF, Rai SK, et al
    The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171389. doi: 10.3899/jrheum.171389.
    PubMed     Text format     Abstract available


  52. GARG S, Tsagaris K, Cozmuta R, Lipson A, et al
    Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171377. doi: 10.3899/jrheum.171377.
    PubMed     Text format     Abstract available


  53. KEELING SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, et al
    Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171459. doi: 10.3899/jrheum.171459.
    PubMed     Text format     Abstract available


  54. MITANDER A, Fei Y, Trysberg E, Mohammad M, et al
    Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171325. doi: 10.3899/jrheum.171325.
    PubMed     Text format     Abstract available


    August 2018
  55. KEELING SO, Vandermeer B, Medina J, Chatterley T, et al
    Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Aug 15. pii: jrheum.171310. doi: 10.3899/jrheum.171310.
    PubMed     Text format     Abstract available


  56. HETLEVIK SO, Flato B, Aalokken TM, Lund MB, et al
    Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
    J Rheumatol. 2018 Aug 1. pii: jrheum.180019. doi: 10.3899/jrheum.180019.
    PubMed     Text format     Abstract available


  57. LIPHAUS BL, Sallum AEM, Aikawa NE, Kiss MHB, et al
    Increased Soluble Cytoplasmic Bcl-2 Protein Serum Levels and Expression and Decreased Fas Expression in Lymphocytes and Monocytes in Juvenile Dermatomyositis.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171248. doi: 10.3899/jrheum.171248.
    PubMed     Text format     Abstract available


  58. TSELIOS K, Gladman DD, Harvey P, Akhtari S, et al
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
    J Rheumatol. 2018 Aug 1. pii: jrheum.171436. doi: 10.3899/jrheum.171436.
    PubMed     Text format     Abstract available


  59. KEELING SO, Bissonauth A, Bernatsky S, Vandermeer B, et al
    Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171307. doi: 10.3899/jrheum.171307.
    PubMed     Text format     Abstract available


  60. BUTENDIECK RR JR, Abril A, Cortese C
    Unusual Presentation of Giant Cell Arteritis in 2 Patients: Uterine Involvement.
    J Rheumatol. 2018;45:1201-1202.
    PubMed     Text format    


    July 2018
  61. GARNIER C, Ribes D, Chauveau D, Huart A, et al
    Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    J Rheumatol. 2018 Jul 15. pii: jrheum.180310. doi: 10.3899/jrheum.180310.
    PubMed     Text format     Abstract available


  62. YUE C, Su J, Gao R, Wen Y, et al
    Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170811. doi: 10.3899/jrheum.170811.
    PubMed     Text format     Abstract available


  63. ZAMPELI E, Kalogirou EM, Piperi E, Mavragani CP, et al
    Tongue Atrophy in Sjogren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?
    J Rheumatol. 2018 Jul 15. pii: jrheum.180101. doi: 10.3899/jrheum.180101.
    PubMed     Text format     Abstract available


  64. CANTI V, Del Rosso S, Tonello M, Luciano R, et al
    Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170751. doi: 10.3899/jrheum.170751.
    PubMed     Text format     Abstract available


  65. BATU ED, Kosukcu C, Taskiran E, Sahin S, et al
    Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171358. doi: 10.3899/jrheum.171358.
    PubMed     Text format     Abstract available


  66. MCDONALD EG, Bissonette L, Ensworth S, Dayan N, et al
    Monitoring of Systemic Lupus Erythematosus Pregnancies: A Systematic Literature Review.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171023. doi: 10.3899/jrheum.171023.
    PubMed     Text format     Abstract available


  67. EUDY AM, Siega-Riz AM, Engel SM, Franceschini N, et al
    Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171066. doi: 10.3899/jrheum.171066.
    PubMed     Text format     Abstract available


  68. ALHARBI S, Ahmad Z, Bookman AA, Touma Z, et al
    Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170953. doi: 10.3899/jrheum.170953.
    PubMed     Text format     Abstract available


  69. HUSSEIN S, Suitner M, Beland-Bonenfant S, Baril-Dionne A, et al
    Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis.
    J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi: 10.3899/jrheum.170837.
    PubMed     Text format     Abstract available


  70. SCHAFER VS, Chrysidis S, Dejaco C, Duftner C, et al
    Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.
    J Rheumatol. 2018 Jul 1. pii: jrheum.171428. doi: 10.3899/jrheum.171428.
    PubMed     Text format     Abstract available


  71. BAICUS C
    At What Age Was Systemic Lupus Erythematosus Diagnosed in This Cohort?
    J Rheumatol. 2018;45:1070.
    PubMed     Text format    


    June 2018
  72. XIE L, Xu J
    Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171290. doi: 10.3899/jrheum.171290.
    PubMed     Text format     Abstract available


  73. TROLDBORG A, Thiel S, Trendelenburg M, Friebus-Kardash J, et al
    The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171033. doi: 10.3899/jrheum.171033.
    PubMed     Text format     Abstract available


  74. ZAMPELI E, Skopouli FN, Moutsopoulos HM
    Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.
    J Rheumatol. 2018;45:877-878.
    PubMed     Text format    


  75. FONGAUFIER C, Guffroy A, Lutz JC
    Tongue and Scalp Necrosis: Simultaneous Initial Complications Revealing Giant Cell Arteritis.
    J Rheumatol. 2018;45:873-874.
    PubMed     Text format    


  76. LABRADOR-HORRILLO M, Selva-O'Callaghan A
    Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
    J Rheumatol. 2018;45:731-732.
    PubMed     Text format    


  77. TSELIOS K, Gladman DD, Touma Z, Su J, et al
    Monophasic Disease Course in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 1. pii: jrheum.171319. doi: 10.3899/jrheum.171319.
    PubMed     Text format     Abstract available


  78. GUDERUD K, Maehlen MT, Nordang GBN, Viken MK, et al
    Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.
    J Rheumatol. 2018 Jun 1. pii: jrheum.170769. doi: 10.3899/jrheum.170769.
    PubMed     Text format     Abstract available


    April 2018
  79. RAISSI TC, Hewson C, Pope JE
    Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
    J Rheumatol. 2018 Apr 15. pii: jrheum.161365. doi: 10.3899/jrheum.161365.
    PubMed     Text format     Abstract available


  80. NANGIT A, Lin C, Ishimori ML, Spiegel BMR, et al
    Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170176. doi: 10.3899/jrheum.170176.
    PubMed     Text format     Abstract available


  81. TANHA N, Hansen RB, Nielsen CT, Faurschou M, et al
    Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170933. doi: 10.3899/jrheum.170933.
    PubMed     Text format     Abstract available


  82. KAWASUMI H, Katsumata Y, Nishino A, Hirahara S, et al
    Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170997. doi: 10.3899/jrheum.170997.
    PubMed     Text format     Abstract available


  83. VEGA-MORALES D, Hernandez-Galarza IJ, Galarza-Delgado DA
    Causes of Hospital Mortality in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in a University Hospital: 1998-2015 Analysis.
    J Rheumatol. 2018;45:583-584.
    PubMed     Text format    


    March 2018
  84. ROMERO-DIAZ J, Acosta-Hernandez RI, Criales-Vera S, Kimura-Hayama E, et al
    Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170330. doi: 10.3899/jrheum.170330.
    PubMed     Text format     Abstract available


  85. YANG J, Yang X, Yang J, Li M, et al
    Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170737. doi: 10.3899/jrheum.170737.
    PubMed     Text format     Abstract available


  86. LIOZON E, de Boysson H, Dalmay F, Gondran G, et al
    Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170455. doi: 10.3899/jrheum.170455.
    PubMed     Text format     Abstract available


  87. FRITZLER MJ, Choi MY, Mahler M
    The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.
    J Rheumatol. 2018;45:444-445.
    PubMed     Text format    


  88. BHANSING KJ, VAN Rosmalen MH, VAN Engelen BG, VAN Riel PL, et al
    Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis.
    J Rheumatol. 2018;45:441-442.
    PubMed     Text format    


  89. TIDWELL WJ, Callen JP
    Koebner Phenomenon in Juvenile Dermatomyositis.
    J Rheumatol. 2018;45:437.
    PubMed     Text format    


  90. DAVIDSON JE, Fu Q, Ji B, Rao S, et al
    Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    J Rheumatol. 2018 Mar 1. pii: jrheum.161554. doi: 10.3899/jrheum.161554.
    PubMed     Text format     Abstract available


    February 2018
  91. YUE C, Li G, Wen Y, Li X, et al
    Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
    PubMed     Text format     Abstract available


  92. CAI F, Han F, Wang H, Han H, et al
    The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
    PubMed     Text format     Abstract available


  93. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170590. doi: 10.3899/jrheum.170590.
    PubMed     Text format     Abstract available


  94. CHEN H, Peng Q, Yang H, Yin L, et al
    Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170544. doi: 10.3899/jrheum.170544.
    PubMed     Text format     Abstract available


  95. ALEXANDERSON H, Regardt M, Ottosson C, Alemo Munters L, et al
    Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    J Rheumatol. 2018 Feb 1. pii: jrheum.161183. doi: 10.3899/jrheum.161183.
    PubMed     Text format     Abstract available


  96. LUCAS S, Chang WL, Merien F
    Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
    J Rheumatol. 2018;45:289-291.
    PubMed     Text format    


  97. CHEN YH, Lu CC, Chen HC
    Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2018;45:286-287.
    PubMed     Text format    


    January 2018
  98. BERNATSKY S, Ramsey-Goldman R, Petri M, Urowitz MB, et al
    Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jan 15. pii: jrheum.170652. doi: 10.3899/jrheum.170652.
    PubMed     Text format     Abstract available


    December 2017
  99. YEUNG Y, Barra LJ
    Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
    J Rheumatol. 2017;44:1942-1943.
    PubMed     Text format    


  100. NAVRATIL M, Ivkovic Jurekovic I
    Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    J Rheumatol. 2017;44:1940.
    PubMed     Text format    


  101. BLOCKMANS D
    Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
    J Rheumatol. 2017;44:1763-1764.
    PubMed     Text format    


    November 2017
  102. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
    PubMed     Text format     Abstract available


  103. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Text format     Abstract available


  104. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
    Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
    J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
    PubMed     Text format     Abstract available


  105. TSELIOS K, Gladman DD, Su J, Ace O, et al
    Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
    J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
    PubMed     Text format     Abstract available


    October 2017
  106. VITIELLO G, Cammelli D
    Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
    J Rheumatol. 2017;44:1566.
    PubMed     Text format    


  107. CHEN Y, Liu J
    What is the Definition of the Anticytoplasmic Autoantibody?
    J Rheumatol. 2017;44:1564.
    PubMed     Text format    


    September 2017
  108. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
    Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
    PubMed     Text format     Abstract available


  109. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
    Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
    PubMed     Text format     Abstract available


  110. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
    Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
    PubMed     Text format     Abstract available



  111. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed     Text format    


  112. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed     Text format    


  113. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Text format     Abstract available


  114. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Text format     Abstract available


    August 2017
  115. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
    Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
    PubMed     Text format     Abstract available


    July 2017
  116. CHEN Z, Wang Y, Kuwana M, Xu X, et al
    HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
    PubMed     Text format     Abstract available


  117. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
    Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
    PubMed     Text format     Abstract available


  118. NAGASHIMA T, Iwamoto M, Minota S
    Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
    J Rheumatol. 2017;44:1099-1100.
    PubMed     Text format    


  119. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
    Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
    PubMed     Text format     Abstract available


    June 2017
  120. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
    Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
    PubMed     Text format     Abstract available


  121. GU K, Gladman DD, Su J, Urowitz MB, et al
    Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
    J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
    PubMed     Text format     Abstract available


  122. KURTZMAN DJB, Weinblatt M, Vleugels RA
    Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    J Rheumatol. 2017;44:850-851.
    PubMed     Text format    


  123. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
    Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
    J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
    PubMed     Text format     Abstract available


  124. HEMKE R, Tzaribachev N, Nusman CM, van Rossum MAJ, et al
    Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.
    J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821.
    PubMed     Text format     Abstract available


    May 2017
  125. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
    Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
    PubMed     Text format     Abstract available


  126. FASANO S, Pierro L, Pantano I, Iudici M, et al
    Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
    PubMed     Text format     Abstract available


  127. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
    Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
    PubMed     Text format     Abstract available


  128. SHI J, Li S, Yang H, Zhang Y, et al
    Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
    PubMed     Text format     Abstract available


  129. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
    Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
    J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
    PubMed     Text format     Abstract available


  130. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
    Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
    PubMed     Text format     Abstract available


  131. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
    Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
    J Rheumatol. 2017;44:711-712.
    PubMed     Text format    


  132. GENEST G, Laskin CA
    Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    J Rheumatol. 2017;44:547-549.
    PubMed     Text format    


    April 2017
  133. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
    PubMed     Text format     Abstract available


  134. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Text format     Abstract available


  135. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Text format     Abstract available


  136. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Text format     Abstract available


  137. YANG N, Bhattacharyya S, Weinblatt M
    Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
    J Rheumatol. 2017;44:541-542.
    PubMed     Text format    


  138. NIHTYANOVA SI, Denton CP
    Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
    J Rheumatol. 2017;44:404-406.
    PubMed     Text format    


    March 2017
  139. ZISMAN D, Gladman DD, Stoll ML, Strand V, et al
    The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    J Rheumatol. 2017;44:342-351.
    PubMed     Text format     Abstract available


  140. HORTON DB, Onel KB, Beukelman T, Ringold S, et al
    Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol. 2017;44:352-360.
    PubMed     Text format     Abstract available


  141. WARD TM, Beebe DW, Chen ML, Landis CA, et al
    Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2017;44:361-367.
    PubMed     Text format     Abstract available


  142. VAN DAALEN EE, Rahmattulla C, Wolterbeek R, Bruijn JA, et al
    Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    J Rheumatol. 2017;44:314-318.
    PubMed     Text format     Abstract available


  143. AESCHLIMANN FA, Angst F, Hofer KD, Cannizzaro Schneider E, et al
    Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.
    J Rheumatol. 2017;44:334-341.
    PubMed     Text format     Abstract available


  144. STOUSTRUP P, Twilt M, Spiegel L, Kristensen KD, et al
    Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.
    J Rheumatol. 2017;44:326-333.
    PubMed     Text format     Abstract available


    February 2017
  145. GUZMAN J, Henrey A, Loughin T, Berard RA, et al
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2017;44:230-240.
    PubMed     Text format     Abstract available


  146. FURUTA S, Chaudhry AN, Arimura Y, Dobashi H, et al
    Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.
    J Rheumatol. 2017;44:216-222.
    PubMed     Text format     Abstract available


    January 2017
  147. THOMAS G, Cohen Aubart F, Chiche L, Haroche J, et al
    Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
    J Rheumatol. 2017;44:24-32.
    PubMed     Text format     Abstract available


    June 2016
  148. NUSMAN CM, Rosendahl K, Maas M
    MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:1257-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: